BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

375 related articles for article (PubMed ID: 6383221)

  • 1. High-dose methylprednisolone in the treatment of bullous pemphigoid.
    Siegel J; Eaglstein WH
    Arch Dermatol; 1984 Sep; 120(9):1157-65. PubMed ID: 6383221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of oral methylprednisolone plus azathioprine or mycophenolate mofetil for the treatment of bullous pemphigoid.
    Beissert S; Werfel T; Frieling U; Böhm M; Sticherling M; Stadler R; Zillikens D; Rzany B; Hunzelmann N; Meurer M; Gollnick H; Ruzicka T; Pillekamp H; Junghans V; Bonsmann G; Luger TA
    Arch Dermatol; 2007 Dec; 143(12):1536-42. PubMed ID: 18087004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The treatment of bullous pemphigoid with tetracycline and niacinamide. A preliminary report.
    Berk MA; Lorincz AL
    Arch Dermatol; 1986 Jun; 122(6):670-4. PubMed ID: 2940979
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Methylprednisolone versus prednisolone methylsulfobenzoate in pemphigoid: a comparative multicenter study].
    Dreno B; Sassolas B; Lacour P; Montpoint S; Lota I; Giordano F; Royer P
    Ann Dermatol Venereol; 1993; 120(8):518-21. PubMed ID: 8304707
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bullous dermatosis. Bullous pemphigoid.
    Vano-Galvan S; Carrillo R; Moreno C; Jaen P
    Neth J Med; 2009 May; 67(5):200-1. PubMed ID: 19581675
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapy of pemphigus and pemphigoid].
    Schaumburg-Lever G
    Z Hautkr; 1986 Jun; 61(11):811-2. PubMed ID: 3526731
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison of oral and topical corticosteroids in patients with bullous pemphigoid.
    Joly P; Roujeau JC; Benichou J; Picard C; Dreno B; Delaporte E; Vaillant L; D'Incan M; Plantin P; Bedane C; Young P; Bernard P;
    N Engl J Med; 2002 Jan; 346(5):321-7. PubMed ID: 11821508
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Cyclosporin in the treatment of bullous pemphigoid: preliminary study].
    Barthélémy H; Thivolet J; Cambazard F; Bendelac A; Mauduit G; Granier F; Frappaz A
    Ann Dermatol Venereol; 1986; 113(4):309-13. PubMed ID: 3532906
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Cutaneous infections in bullous pemphigoid patients treated with topical corticosteroids].
    Boughrara Z; Ingen-Housz-Oro S; Legrand P; Duong TA; Roujeau JC
    Ann Dermatol Venereol; 2010 May; 137(5):345-51. PubMed ID: 20470914
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Bullous pemphigoid in childhood].
    Mensing H; Brehm H; Nasemann T
    Hautarzt; 1984 May; 35(5):254-8. PubMed ID: 6378831
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A retrospective analysis of patients with bullous pemphigoid treated with methotrexate.
    Kjellman P; Eriksson H; Berg P
    Arch Dermatol; 2008 May; 144(5):612-6. PubMed ID: 18490587
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mycophenolate mofetil therapy for pediatric bullous pemphigoid.
    Seminario-Vidal L; Sami N; Miller J; Theos A
    Dermatol Online J; 2015 Aug; 21(8):. PubMed ID: 26437160
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of pemphigus vulgaris with brief, high-dose intravenous glucocorticoids.
    Werth VP
    Arch Dermatol; 1996 Dec; 132(12):1435-9. PubMed ID: 8961871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. "Half-half" blisters in bullous pemphigoid successfully treated with adjuvant high-dose intravenous immunoglobulin.
    Pacheco D; Lopes L; Soares-Almeida L; Marques MS; Filipe P
    Acta Dermatovenerol Alp Pannonica Adriat; 2012 Sep; 21(3):59-61. PubMed ID: 23267874
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmapheresis therapy in pemphigus vulgaris and bullous pemphigoid.
    Mazzi G; Raineri A; Zanolli FA; Da Ponte C; De Roia D; Santarossa L; Guerra R; Orazi BM
    Transfus Apher Sci; 2003 Feb; 28(1):13-8. PubMed ID: 12620264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of cost of immune globulin intravenous therapy to conventional immunosuppressive therapy in treating patients with autoimmune mucocutaneous blistering diseases.
    Daoud YJ; Amin KG
    Int Immunopharmacol; 2006 Apr; 6(4):600-6. PubMed ID: 16504922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Dyshidrosiform bullous pemphigoid].
    Mohr C; Duschet P; Bonsmann G; Luger TA; Gschnait F; Schwarz T
    Hautarzt; 1993 Dec; 44(12):785-8. PubMed ID: 8113043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of bullous pemphigoid with erythromycin].
    Mensing H; Krausse S
    Med Klin (Munich); 1990 Aug; 85(8):481-4. PubMed ID: 2233601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy and safety of azathioprine and dapsone as an adjuvant in the treatment of bullous pemphigoid.
    Tirado-Sánchez A; Díaz-Molina V; Ponce-Olivera RM
    Allergol Immunopathol (Madr); 2012; 40(3):152-5. PubMed ID: 21497011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment of bullous pemphigoid with pulsed intravenous cyclophosphamide.
    Itoh T; Hosokawa H; Shirai Y; Horio T
    Br J Dermatol; 1996 May; 134(5):931-3. PubMed ID: 8736339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.